Table 1: Comparison of demographic, clinical, and laboratory data of cases versus control group.

Cases with CADControl (no CAD)Significance
Mean ± S.D.Mean ± S.D.(P value)

Age (years) 6 9 . 5 1 ± 2 . 2 9 6 9 . 0 6 ± 1 . 6 4 .17
BMI (kg/m2) 2 7 . 9 9 ± 3 . 0 8 2 3 . 1 0 ± 0 . 7 1 .0001
SBP (mmHg) 1 4 6 . 7 0 ± 9 . 0 2 1 2 5 . 2 0 ± 7 . 2 8 .0001
DBP (mmHg) 9 1 . 7 6 ± 9 . 3 6 7 5 . 2 0 ± 7 . 1 4 .0001
FPG (mg/dL) 8 7 . 9 5 ± 1 2 . 7 1 7 9 . 0 8 ± 5 . 4 9 .0001
Serum creatinine (mg/dL) 1 . 0 9 ± 0 . 1 9 1 . 0 2 ± 0 . 0 9 .004
Total cholesterol (mg/dL) 2 0 9 . 5 3 ± 3 6 . 2 0 1 3 2 . 8 4 ± 1 0 . 1 5 .0001
TG (mg/dL) 1 6 1 . 6 1 ± 5 3 . 2 7 8 0 . 2 4 ± 7 . 0 9 .0001
LDL-c (mg/dL) 1 4 2 . 8 2 ± 3 5 . 8 4 7 6 . 8 8 ± 7 . 4 9 .0001
HDL-c (mg/dL) 3 7 . 9 6 ± 4 . 9 7 4 7 . 6 6 ± 5 . 0 6 .0001
Cortisol (nmol/L) 3 5 9 . 1 0 ± 1 3 7 . 4 7 2 2 0 . 1 4 ± 4 5 . 0 1 .0001
Free testosterone (pg/mL) 7 0 . 7 5 ± 1 1 . 9 5 1 6 4 . 6 0 ± 2 9 . 5 6 .0001
hs CRP (mg/L) 1 4 . 8 1 ± 9 . 7 4 1 . 4 5 ± 0 . 6 0 .0001
IL-6 (ng/L) 7 . 3 3 ± 3 . 2 2 1 . 9 4 ± 0 . 5 9 .0001
Fibrinogen (g/L) 5 . 6 6 ± 1 . 1 9 2 . 9 3 ± 0 . 6 4 .0001
PAI-1 (ng/mL) 5 6 . 0 5 ± 1 3 . 5 6 2 4 . 2 4 ± 9 . 3 7 .0001

BMI: body mass index, DBP: diastolic blood pressure, FPG: fasting plasma glucose, HDL-c: high-density lipoprotein-cholesterol, hsCRP: high sensitive C-reactive protein, IL-6: interleukin-6, LDL-c: low-density lipoprotein-cholesterol, PAI-1: plasminogen activator inhibitor-1, Tg: triglycerides.